3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Phase 2
1
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
6
Gynecologic
5
Thoracic
2
Other solid neoplasm
2
Sarcoma
1
Conditions
Stomach Neoplasms
2
Peritoneal Neoplasms
2
Mesothelioma, Malignant
2
Mesothelioma
2
Colonic Neoplasms
2
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pleural Effusion, Malignant
1
Pelvic Neoplasms
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Myeloproliferative Disorder, Chronic, with Eosinophilia
1
Liposarcoma
1
Fallopian Tube Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colorectal Neoplasms
1
Carcinoma
1
Abdominal Neoplasms
1
Interventions
pembrolizumab
9
Hyperthermic Intraperitoneal Chemotherapy
3
fludarabine
2
budigalimab
2
Nivolumab
2
Ipilimumab
2
Cytoreduction Surgical Procedures
2
Cyclophosphamide
2
Cisplatin
2
venetoclax
1
tocilizumab
1
tislelizumab
1
talazoparib
1
spartalizumab
1
sodium thiosulfate
1
rovalpituzumab tesirine
1
regorafenib
1
milademetan
1
irinotecan sucrosofate
1
fludarabine phosphate
1
epacadostat
1
entinostat
1
atezolizumab
1
X-Rays
1
Surgical Procedures, Operative
1
Specimen Handling
1
Sirolimus
1
Quality of Life
1
Polymerase Chain Reaction
1
Platinum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Cytoreduction Surgical Procedures
×
Other solid neoplasm
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled
NCT00454519
2009-02-13
IPHC
Wuhan University
Phase 2
Unknown
60 enrolled